Cheung Siu Tim
Li Ka Shing Institute of Health Sciences
ST Cheung focuses on the investigation of molecular basis of human cancer, aim to improve treatment strategies and ultimately patient survival. The team has deciphered liver cancer expression profiles and metastasis associated genes. Continuation research included identification of potential therapeutic target, the novel growth factor granulin-epithelin precursor (GEP), and consolidated the roles on cancer growth, invasion, drug resistance, cancer stem cell properties, immunotherapy and antibody targeted therapy.
Novel Targeted Therapeutics; Drug Resistance; Cancer Immunotherapy
Cheung PF, Cheung TT, Yip CW, Ng LW, Fung SW, Lo CM, Fan ST, Cheung ST (correspondence). Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma. Oncotarget 2016; 7: 21644-57.